DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20220551

The epidemiological profile of women screened for precancerous cervical lesions at Benjamin Ngoubou Regional Hospital in Tchibanga, Gabon

Nathalie Ambounda Ledaga, Sylvian Honore Woromogo, Felicite-Emma Yagata-Moussa, Astride Smeige Mihindou, Vicky Noel Simo Tekem, Alain Jepang Kouanang

Abstract


Background: Cervical cancer is the second most common cancer after breast cancer, with about 528,000 new cases reported per year. This study aimed at determining the epidemiological profile of women screened for precancerous cervical lesions in the region of Tchibanga, Gabon.

Methods: A descriptive cross-sectional study was conducted with 144 women as sample for study Using Statistical Package for social sciences (SPSS) software version 20.0, the socio-demographic, epidemiological characteristics and gynaeco-obstetrical history of the participants were obtained and presented by simple frequencies. The relative socioeconomic status of screened females was measured using the simplified calculation of the socio-economic position index.

Results: The under 25 age group accounted for 32%. Non-menopausal women accounted for 86.8% and menopausal women 13.2% in the sample in this study. Women with at least 3 partners accounted for 88.3% of participants diagnosed with dysplasia. Participants with chlamydia accounted for 53.2% of women diagnosed with Cervical Intraepithelial Neoplasia (CIN). Multigestures and large multigestures accounted for 70.6% of participants with dysplasia. The prevalence of precancerous states was 11.8%, classified into CIN 1/condylomas, CIN 2 and CIN 3/CIS.

Conclusions: Making screening a regular activity is important. Awareness-raising sessions on the benefits of screening and the fight against sexually transmitted diseases should be conducted, as well as the early treatment of Chlamydia infections.

 


Keywords


Epidemiological profile, Screening, Precancerous cervical lesions

Full Text:

PDF

References


Human papillomavirus (HPV) and cancer of the cervix. Available at: https://www.who.int/en/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-cancer. Accessed on 17 July 2019.

Gravitt PE, Winer RL. Natural History of HPV Infection across the Lifespan: Role of Viral Latency. Viruses. 2017;9(10):2.

Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al. Cancer incidence and mortality worldwide. Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-86.

Fokom-Domgue J, Vassilakos P, Petignat P. Is screen-and-treat approach suited for screening and management of precancerous cervical lesions in Sub-Saharan African? Prev Med. 2014;65:138-40.

World Health Organization. The fight against cervical cancer: a guide to essential practices. Available at: https://apps.who.int/iris/bitstream/handle/10665/144785/9789241548953_eng.pdf. Accessed on 22 July 2019.

Sylvia Bongo Ondimba Foundation. Acting Against Cancer-Initiatives for Women-Our Initiatives-Sylvia Bongo Ondimba Foundation. 2019. Available at: http://www.sylviabongoondimba.org/our-Initiatives-/initiatives-for-women/agir-contr(le-cancer. Accessed on 16 August 2019.

Schwartz D. Statistical methods for Physicians and Biologists. Edition Flammarion Medecins Sciences, 1969

Genoud PA. Indice de position socioéconomique (IPSE): un calcul simplifié. Fribourg: Université de Fribourg. 2011 Available at: http://www3.uni fr.ch/cerf/fr/indice-de-position-socioéconomique.html. Accessed on 16 August 2021.

Adefuye PO, Dada OA, Adefuye BO, Shorunmu TO, Akinyemi BO, Idowu-Ajiboye BO. Feasibility, acceptability, and effectiveness of visual inspection of the cervix with acetic acid and cryotherapy for dysplasia in Nigeria. Int J Gynaecol Obstet. 2015;129(1):62-6.

Aboubacary K. Evaluation of screening activities for cervical dysplastic and cancerous lesions by visual tests (IVA-IVL) at the CHU Gabriel Touré and the CSREFs of communes IV and V of the district of Bamako [Thesis]. Available at: http://www.keneya.net/fmpos/theses/2015/med/pdf/15M106.pdf. Accessed on 16 August 2021.

Murillo R, Luna J, Gamboa O, Osorio E, Bonilla J, Cendales R. Cervical cancer screening with naked-eye visual inspection in Colombia. Int J Gynaecol Obstet. 2010;109(3):230-4.

General Directorate of Statistics. Overall results of the 2013 Gabon General Population and Housing Census (RGPL2013). 2015;247.

World Health Organization. The fight against cervical cancer: a guide to essential practices. 2017. Available at: http://apps.who.int/iris/bitstream/10665/254713/1/9789242548952-eng.pdf?ua=1 4. Accessed on 22 July 2019.

Lansac J. Cancer of the cervix. Medical practice, 32nd ed. 1988;9-27.

Lansac J, Lecompte P. Gynecology for the practitioner. 4th. Paris. 1994;81-99.

Lehtinen M, Ault KA, Lyytikainen E, Dillner J, Garland SM, Ferris DG et al. Chlamydia trachomatis infection and risk of cervical intraepithelia neoplasia. Sex Transm Infect. 2011;87(5):372-6.

Leno DWA, Diallo FD, Camara AY, Magassouba M, Komano FD, Traore A et al. Analysis of uterus cervical cancer screening campaign results in Conakry. Guinea. Bull Cancer. 2017;104(11):914-20.

Tebeu PM, Sandjong I, Nkele N, Fokoua S, Achu P, Kouam L et al. Precancerous lesions of the cervix in rural zone: a cross sectional study. Med Afr Noire. 2005;52(1):27-31.

Ministry of Health. Strategic Plan for Tobacco Control in Gabon 2016-2021 [Internet]. Ministry of Health; 2015. Available at: http://untobaccocontrol.org. Accessed on 16 August 2019.

Schiffman MH, Haley NJ, Felton JS. Biochemical epidemiology of cervical neoplasia measuring cigarette smoke constituents in the cervix. Cancer Res. 1987;47(14):3886-8.

Sellors JW. Colposcopy and Treatment of intraepithelial cervical Neoplasia: manual for beginner. International Agency for Research on Cancer Lyon. 2003.